First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes-Reference-Cited by-同舟云学术

First‐line treatment of stage IIB to stage IV classical Hodgkin lymphoma in Italy, Israel, and Spain: Patient characteristics, treatment patterns, and clinical outcomes

Published:2022-04-19 Issue:2 Volume:3 Page:415-425
ISSN:2688-6146
Container-title:eJHaem
language:en
Short-container-title:eJHaem

Author:

Avigdor Abraham¹²^ORCID,Trinchese Fabrizio³,Gavini Francois³,Bent‐Ennakhil Nawal³,Dalal Mehul⁴,Zomas Athanasios³,Gettner Broun Sharmeen⁵^ORCID,Gini Guido⁶

Affiliation:

1. The Chaim Sheba Medical Center Institute of Hematology Ramat Gan Israel

2. Sackler Faculty of Medicine Tel Aviv University Tel Aviv Israel

3. Takeda Pharmaceuticals International AG Zurich Switzerland

4. Millennium Pharmaceuticals, Inc. A wholly owned subsidiary of Takeda Pharmaceutical Company Ltd Cambridge Massachusetts USA

5. Kantar Paris France

6. Ospedali Riuniti di Ancona Clinic of Hematology, Ancona, Italy

Publisher

Wiley

Subject

General Earth and Planetary Sciences

Link